Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000891554-01-501696
Filing Date
2001-03-30
Accepted
2001-03-30 00:00:00
Documents
8
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d25170_10k.txt 10-K 214749
2 SEVERANCE AGREEMENT d25170_ex10-21.txt EX-10.21 41954
3 LOAN AND SECURITY AGREEMENT d25170_ex10-22.txt EX-10.22 21736
4 PROMISSORY NOTE d25170_ex10-23.txt EX-10.23 3757
5 LOAN AND SECURITY AGREEMENT d25170_ex10-24.txt EX-10.24 21704
6 EMPLOYMENT AGREEMENT d25170_ex10-25.txt EX-10.25 18946
7 EMPLOYMENT AGREEMENT d25170_ex10-26.txt EX-10.26 18659
8 CONSENT OF KPMG LLP d25170_ex23-1.txt EX-23.1 953
  Complete submission text file 0000891554-01-501696.txt   344803
Mailing Address 1000 MARINA BLVD STE 200 BRISBANE CA 94005
Business Address 1000 MARINA BLVD STE 200 BRISBANE CA 94005 6506241000
VAXGEN INC (Filer) CIK: 0001036968 (see all company filings)

EIN.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26483 | Film No.: 1586847
SIC: 2834 Pharmaceutical Preparations